Upgrade to SI Premium - Free Trial

Gossamer Bio Inc. (GOSS)

0.16 -0.01 (5.88%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/11/26)

Latest Headlines

Form DEF 14A Gossamer Bio, Inc. For: Jul 14 June 9, 2026 4:19 PM - SEC Filing Form SCHEDULE 13G Gossamer Bio, Inc. Filed by: Context Capital Management, LLC June 9, 2026 8:44 AM - SEC Filing Form 4 Gossamer Bio, Inc. For: Jun 04 Filed by: Quisel John D June 5, 2026 5:46 PM - SEC Filing Form 4 Gossamer Bio, Inc. For: Jun 04 Filed by: Drynan Skye June 5, 2026 4:31 PM - SEC Filing Form 4 Gossamer Bio, Inc. For: Jun 04 Filed by: Daniel Thomas O June 5, 2026 4:30 PM - SEC Filing Form 4 Gossamer Bio, Inc. For: Jun 04 Filed by: Cox Russell J. June 5, 2026 4:30 PM - SEC Filing Form 4 Gossamer Bio, Inc. For: Jun 04 Filed by: Milligan Sandra June 5, 2026 4:28 PM - SEC Filing Form 4 Gossamer Bio, Inc. For: Jun 04 Filed by: Nathan Steven D June 5, 2026 4:28 PM - SEC Filing Gossamer Bio completes early settlement of convertible notes exchange June 5, 2026 6:09 AM - StreetInsider Form 8-K Gossamer Bio, Inc. For: Jun 03 June 5, 2026 6:04 AM - SEC Filing Form 8-K Gossamer Bio, Inc. For: Jun 04 June 5, 2026 6:01 AM - SEC Filing Gossamer Bio reports 90.5% participation in convertible note exchange June 3, 2026 8:01 AM - StreetInsider Gossamer Bio, Inc. Announces Early Tender Results and Early Settlement for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes June 3, 2026 8:00 AM - BizWire Form 8-K Gossamer Bio, Inc. For: Jun 02 June 2, 2026 8:01 AM - SEC Filing Gossamer Bio, Inc. Announces Extension of Early Tender Date for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes June 2, 2026 8:00 AM - BizWire Gossamer Bio Inc. (GOSS) PT Lowered to $0.28 at Barclays May 19, 2026 3:58 AM - StreetInsider Gossamer Bio Inc. (GOSS) Misses Q1 EPS by 3c May 18, 2026 7:51 AM - StreetInsider Form PRE 14A Gossamer Bio, Inc. For: May 18 May 18, 2026 7:09 AM - SEC Filing Form DEFA14A Gossamer Bio, Inc. May 18, 2026 7:08 AM - SEC Filing Form 8-K Gossamer Bio, Inc. For: May 18 May 18, 2026 7:07 AM - SEC Filing Gossamer Bio launches debt exchange offer to eliminate $120 million May 18, 2026 7:06 AM - StreetInsider Gossamer Bio, Inc. Launches Exchange Offer and Consent Solicitation Intended to Eliminate Over $120 Million of Debt with Existing Noteholder Support May 18, 2026 7:05 AM - BizWire Gossamer Bio Announces First Quarter 2026 Financial Results and Provides Business Update May 18, 2026 7:00 AM - BizWire Form 10-Q Gossamer Bio, Inc. For: Mar 31 May 15, 2026 4:04 PM - SEC Filing Gossamer Bio to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 18, 2026 May 15, 2026 7:01 AM - BizWire Form SCHEDULE 13G/A Gossamer Bio, Inc. Filed by: Octagon Capital Advisors LP May 14, 2026 4:02 PM - SEC Filing Form ARS Gossamer Bio, Inc. For: Apr 24 April 24, 2026 4:04 PM - SEC Filing Form DEFA14A Gossamer Bio, Inc. April 24, 2026 4:02 PM - SEC Filing Form DEF 14A Gossamer Bio, Inc. For: Apr 24 April 24, 2026 4:02 PM - SEC Filing Form 8-K Gossamer Bio, Inc. For: Apr 08 April 9, 2026 4:01 PM - SEC Filing Form SCHEDULE 13G/A Gossamer Bio, Inc. Filed by: VANGUARD GROUP INC March 27, 2026 9:31 AM - SEC Filing Form SCHEDULE 13G/A Gossamer Bio, Inc. Filed by: 683 Capital Management, LLC March 24, 2026 4:49 PM - SEC Filing Cantor Fitzgerald Downgrades Gossamer Bio Inc. (GOSS) to Neutral March 23, 2026 3:12 AM - StreetInsider Form 4 Gossamer Bio, Inc. For: Mar 19 Filed by: Aranda Richard March 20, 2026 4:22 PM - SEC Filing Form 4 Gossamer Bio, Inc. For: Mar 19 Filed by: Peterson Caryn March 20, 2026 4:21 PM - SEC Filing Form 4 Gossamer Bio, Inc. For: Mar 19 Filed by: Smith Robert Paul JR March 20, 2026 4:20 PM - SEC Filing Form 4 Gossamer Bio, Inc. For: Mar 19 Filed by: Hasnain Faheem March 20, 2026 4:18 PM - SEC Filing Form 4 Gossamer Bio, Inc. For: Mar 19 Filed by: Giraudo Bryan March 20, 2026 4:17 PM - SEC Filing Form 4 Gossamer Bio, Inc. For: Mar 19 Filed by: Christian Waage March 20, 2026 4:15 PM - SEC Filing Form EFFECT Gossamer Bio, Inc. March 19, 2026 6:08 AM - SEC Filing Gossamer Bio, Inc. Investigated by the Portnoy Law Firm March 18, 2026 9:01 AM - Globe NewsWire Gossamer Bio Inc. (GOSS) Misses Q4 EPS by 2c, Beats on Revenue March 17, 2026 4:13 PM - StreetInsider Form POS AM Gossamer Bio, Inc. March 17, 2026 4:10 PM - SEC Filing Form 8-K Gossamer Bio, Inc. For: Mar 17 March 17, 2026 4:04 PM - SEC Filing Form 10-K Gossamer Bio, Inc. For: Dec 31 March 17, 2026 4:03 PM - SEC Filing Form POSASR Gossamer Bio, Inc. March 17, 2026 4:02 PM - SEC Filing Gossamer Bio Announces Fourth Quarter and Full-Year 2025 Financial Results and Provides Corporate Update March 17, 2026 4:01 PM - BizWire Full Article List